|
Specifications:
Molecular weight: 47kDa (GST fusion protein).
Concentration: 1 mg/ml (PBS+1mM EDTA, pH7.4) 47kDa (GST fusion protein). Purity: > 95% by SDS-PAGE analysis. Endotoxin level: < 0.01 ng/mg (0.1 EU/µg). Storage: -70°C. Pack Size: 20 µg
Features:
* By injecting sRANKL, novel osteopenia model mice were established in only 50 hours.
* Degree of bone loss can be controlled by changing doses of sRANKL
* High Activity and low endotoxin level.
* sRANKL can be used in establishing osteopenia model for in vivo screening of drugs for osteoporosis, determination of effect and mechanism, evaluation of bone anabolic drugs.
|
|